INVITAE CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0006 USD | -88.00% |
|
-82.86% | -99.90% |
| Apr. 25 | Labcorp beats quarterly estimates on strong testing demand | RE |
| Apr. 25 | Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| INVITAE CORPORATION | Bio Diagnostics & Testing | -88.00% | -82.86% | -99.90% | -99.96% | -100.00% | 172K |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- NVTA.Q Stock
- Charts Invitae Corporation
- Comparison Chart